Cepheid Gains IVDR CE Mark for Xpert GI Panel
SUNNYVALE, Calif., May 13, 2026 Cepheid, a Danaher company, announced that it has received CE marking under the European...
Clinical Study
Advertisement
Pfizer Wins EU Approval for HYMPAVZI in Hemophilia
NEW YORK, May 13, 2026 Pfizer has received European Commission approval for HYMPAVZI® (marstacimab) for the treatment of adults...
Exero Medical Highlights FDA Breakthrough xBar Study at ASCRS 2026
JERSEY CITY, N.J. and OR YEHUDA, Israel, May 11, 2026 Exero Medical has announced positive pivotal clinical study results...
SetPoint Medical Starts MS Study for Neuroimmune Therapy
VALENCIA, California, April 30, 2026 SetPoint Medical announced the first patients enrolled in a pilot clinical study evaluating its...
Anaxiom AVOS Device Shows Safe Early Obesity Results
LAGUNA HILLS, Calif., April 2026 Anaxiom Corporation has announced encouraging early clinical results from its first-in-human study of the...
Advertisements
Protaryx Wins FDA 510(k) Clearance for Cardiac Device
BALTIMORE, MARYLAND, USA, April 13, 2026 Protaryx Medical has received U.S. FDA 510(k) clearance for its Transseptal Puncture Device,...
MaaT Pharma CHRONOS Data Reveals Poor aGvHD Survival
LYON, France, April 1, 2026 MaaT Pharma has announced the publication of CHRONOS study data in the peer-reviewed Bone...
Caris Detect Study Shows Strong Early Cancer Detection
IRVING, Texas, USA, March 31, 2026 Caris Life Sciences has announced final results from the Achieve 1 study, demonstrating...
IceCure Reports Strong 5-Year Results in Kidney Cancer
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
Biodesix Reports Strong Lung Cancer Biomarker Validation Data
Louisville, Colorado, USA | March 20, 2026 Biodesix Inc. has announced the publication of the largest lung nodule biomarker...
Advertisement
